Abstract: Techniques are provided for receiving a first set of historical agricultural data and a second set of historical agricultural data; generating a plurality of projected target yield ranges using the first set and the second set of historical agricultural data by generating a historic yield distribution; generating one or more yield ranking scores for one or more fields of a grower using the first set of historical agricultural data, and assigning a projected target yield range of the plurality of projected target yield ranges to each of the one or more fields based on the one or more yield ranking scores to generate assigned projected target yield ranges; receiving a third set of historical agricultural data comprising seed optimization data, and generating a recommended change in seed population or a recommended change in seed density; causing displaying the yield improvement recommendation for each of the one or more fields.

Abstract: Teeth are screened for periodontal disease using digitized images manipulated and annotated on a processor. A digitized radiographic image of a tooth shows locations of a bone boundary and a cemento-enamel junction (CEJ) of the tooth. The digitized radiographic image is marked on the processor with a location on the bone boundary and with a pair of CEJ points at opposite ends of the CEJ visible in the radiograph. A ratio between (a) a distance between the bone boundary location and the adjacent CEJ point as numerator and (b) a distance between the CEJ points as denominator is calculated on the processor and compared with a threshold ratio-value for a corresponding tooth from a database accessible by the processor. A calculated ratio-value which is greater than the database threshold ratio-value is indicative of periodontal disease in the tooth. The probability of the correct diagnostic decision is determined by the relative magnitude of the calculated ratio-value and the threshold ratio-value.

Abstract: The invention relates to pharmaceutical compositions for direct systemic introduction, are also known as DSI pharmaceutical compositions, for used as human veterinary pharmaceutical compositions. In one embodiment, the invention relates to a pharmaceutical composition for direct system introduction comprising bovine gelatin, mannitol, an optional surfactant, an optional flavorant, and an active pharmaceutical ingredient. A DSI pharmaceutical composition of the invention has a disintegration time of 7 seconds or less in deionized water maintained at 37.0° C.±0.5° C. The invention also relates to a method of delivering an active pharmaceutical ingredient to an animal comprising the step of placing a DSI pharmaceutical composition of the invention into a mucosal cavity of an animal to be treated with the active pharmaceutical ingredient and to the corresponding methods of treatment.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Systems and methods for determining the state of health for a capacitor module are provided. In some embodiments, a method for monitoring the health of a capacitor module comprising an array of capacitors is provided. The method may include steps for disabling a charger coupled to an array of capacitors of the capacitor module, determining if the capacitor module is healthy based at least on operating values of the capacitor module, and enabling a write back mode for the memory module if the capacitor module is determined to be healthy.

Abstract: The invention relates to pharmaceutical compositions for direct systemic introduction, are also known as DSI pharmaceutical compositions, for used as human veterinary pharmaceutical compositions. In one embodiment, the invention relates to a pharmaceutical composition for direct system introduction comprising bovine gelatin, mannitol, an optional surfactant, an optional flavorant, and an active pharmaceutical ingredient. A DSI pharmaceutical composition of the invention has a disintegration time of 7 seconds or less in deionized water maintained at 37.0° C.±0.5° C. The invention also relates to a method of delivering an active pharmaceutical ingredient to an animal comprising the step of placing a DSI pharmaceutical composition of the invention into a mucosal cavity of an animal to be treated with the active pharmaceutical ingredient and to the corresponding methods of treatment.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Systems and methods for determining the state of health for a capacitor module are provided. In some embodiments, a method for monitoring the health of a capacitor module comprising an array of capacitors is provided. The method may include steps for disabling a charger coupled to an array of capacitors of the capacitor module, determining if the capacitor module is healthy based at least on operating values of the capacitor module, and enabling a write back mode for the memory module if the capacitor module is determined to be healthy.

Abstract: Systems and methods for determining the state of health for a capacitor module are provided. In some embodiments, a method for monitoring the health of a capacitor module comprising an array of capacitors is provided. The method may include steps for disabling a charger coupled to an array of capacitors of the capacitor module, determining if the capacitor module is healthy based at least on operating values of the capacitor module, and enabling a write back mode for the memory module if the capacitor module is determined to be healthy.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: The invention relates to pharmaceutical compositions for direct systemic introduction, are also known as DSI pharmaceutical compositions, for used as human veterinary pharmaceutical compositions. In one embodiment, the invention relates to a pharmaceutical composition for direct system introduction comprising bovine gelatin, mannitol, an optional surfactant, an optional flavorant, and an active pharmaceutical ingredient. A DSI pharmaceutical composition of the invention has a disintegration time of 7 seconds or less in deionized water maintained at 37.0° C.±0.5° C. The invention also relates to a method of delivering an active pharmaceutical ingredient to an animal comprising the step of placing a DSI pharmaceutical composition of the invention into a mucosal cavity of an animal to be treated with the active pharmaceutical ingredient and to the corresponding methods of treatment.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said compositon dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: A solar collector controller that can process solar field control commands can include a network interface that can receive a variable-length data packet with a collector controller. The collector controller can control one or more solar collectors. In addition, the variable-length data packet can include a header segment identifying a command to be performed by the collector controller and a data segment having one or more parameters associated with the command. The data segment can have a length that depends on a type of the command. Moreover, the solar collector controller can include a processor that can execute the command in response to receiving the data packet.

Abstract: Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said compositon dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.

Abstract: Systems and methods for determining the state of health for a capacitor module are provided. In some embodiments, a method for monitoring the health of a capacitor module comprising an array of capacitors is provided. The method may include steps for disabling a charger coupled to an array of capacitors of the capacitor module, determining if the capacitor module is healthy based at least on operating values of the capacitor module, and enabling a write back mode for the memory module if the capacitor module is determined to be healthy.

Abstract: A system for causing a solar collector to track the sun can include a collector controller that can control one or more solar collectors in a solar field, where the collector controller has one or more processors. The collector controller can estimate a sun angle, determine an angle of the one or more solar collectors with respect to the sun based at least partly on an inclination angle of the one or more solar collectors, and compare the estimated sun angle with the angle of the one or more solar collectors to determine a desired movement of the one or more solar collectors. Further, the collector controller can actuate the motor to effectuate the desired movement until the angle of the one or more solar collectors is within a hysteresis value within a virtual track deadband.